BioTech HLN

Haleon Completes Tender Offer For 2027 Notes, Sets Settlement For August 21

(RTTNews) - Haleon plc (HLN), a consumer health company, announced the pricing terms, expiration, and results of its cash tender offer for its outstanding $1.999 billion 3.375% Fixed Rate Senior Notes due March 2027.

The offer, made through Haleon US Capital LLC, its wholly owned subsidiary, expired at 5:00 p.m. New York City time on August 18, 2026. According to the company, $1.34 billion of the notes were validly tendered and accepted for purchase.

The total consideration per $1,000 principal amount was calculated at $996.23, based on a fixed spread of 10 basis points over the 3.875% U.S. Treasury due March 31, 2027. In addition to the purchase price, accrued and unpaid interest will be paid up to, but not including the settlement date.

The consummation of the tender offer is subject to Haleon successfully completing its new USD- denominated Senior Fixed Rate Notes announced on August 11, 2026. The company expects this condition to be satisfied, with settlement scheduled for August 21, 2026.

The notes are fully and unconditionally guaranteed by Haleon. Management emphasized that the transaction is part of its ongoing capital management strategy, aimed at optimizing its debt profile.

HLN has traded between $8.65 and $11.28 over the past year. The stock closed Tuesday's trading at $9.72, up 1.46%. In pre-market trading the stock is at $9.74, up 0.21%.

RTTNews
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.
More articles by this source

Tags

Stocks Mentioned

Latest Articles

Data is currently not available